Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02562118
Recruitment Status : Unknown
Verified May 2016 by National University Hospital, Singapore.
Recruitment status was:  Recruiting
First Posted : September 29, 2015
Last Update Posted : June 1, 2016
Sponsor:
Collaborator:
Eisai Co., Ltd.
Information provided by (Responsible Party):
National University Hospital, Singapore